Launch under your brand
White label telehealth: three ways to launch under your own brand
Self-serve platform, done-for-you launch or custom build. Here is how they compare on what you get, who brings you patients, speed and control, including where ModFX is not the right fit.
The short answer
White label telehealth means launching a telehealth brand under your own name on someone else’s medical group, pharmacy network and software. There are three ways to do it: a self-serve white label platform, a done-for-you launch such as ModFX on Heroship or Wizlo, or a custom build. The right one depends on who brings you patients, speed and control.
Written by Justin Ingram, founder of ModFX Media20+ years in medical sales, built and ran seven clinics, owns a 503A compounding pharmacy and serves as CMO of Heroship and ThriveLab.Last updated October 8, 2026Which treatments a patient can receive still depends on the medication and state rules.
What is white label telehealth, really?
White label telehealth is renting the hard parts. A vendor supplies the licensed medical group, the pharmacy network and the software. You supply the brand that patients see.
Platforms in this space include Rimo, TurboPills, Cuvo, Bask, OpenLoop, MD Integrations and Beluga. Some give you a storefront you set up yourself. Others supply the provider and pharmacy layer through an integration your developers connect to. They are real options, and for some founders they are the right one.
What almost none of them do is bring you patients. A white label telehealth platform gets you open for business, not busy. That gap is where most new brands stall.
Three ways to launch under your own brand, compared
| Self-serve white label platform | Done-for-you launch (ModFX on Heroship or Wizlo) | Custom build | |
|---|---|---|---|
| What you get | Software, a medical group and pharmacy access that you configure | The platform plus your brand, site, launch and ongoing marketing, built with you | Exactly what you design, built by your own engineers |
| Who gets you patients | You do | ModFX runs the marketing | You do, or an agency you hire |
| Speed | Often the quickest path to a live storefront | Scoped to your states and product mix; typically faster than a custom build | Slowest; typically many months before the first patient |
| Control and data | Whatever the vendor’s contract allows | Your brand; data and exit terms are in the platform agreement, which we walk through before you sign | Full control and full responsibility, including compliance |
| Best for | Founders with an audience or in-house marketing who want to test fast | Founders who want one team accountable for launch and growth | Funded companies with engineers, a medical group and compliance staff |
“Why not just use Cuvo or Rimo?” You might. If you already have an audience that trusts you, a self-serve platform can be a smart, low-commitment test. If you do not, the platform is the easy part. The hard part is acquiring patients at a cost that leaves a margin, and that is where a turnkey telehealth platform leaves you on your own.
What white label actually includes: a vendor checklist
Here is the detail most founders miss until it is too late. If the vendor’s medical group holds the charts and the vendor’s merchant account holds the subscriptions, leaving can mean asking every active patient to start a new intake and re-enter their card. Some will not. Ask how a migration works before you sign, not after.
- ✓Provider licensure by state. Which states the providers are licensed in, for which treatments, and who the medical group and medical director are.
- ✓Pharmacy network and compounder disclosure. Which pharmacies fill your orders, how orders are routed, and how your marketing will name the compounding pharmacy where required.
- ✓Payment processing approval. Whose merchant account it is, and whether the processor has approved telehealth subscriptions.
- ✓LegitScript support. LegitScript is the third-party certification Google and Meta check before they let a telehealth brand advertise prescription treatments. Ask who applies and who keeps it current. Our LegitScript certification page covers the process.
- ✓Data ownership. Who owns the patient records, the email and SMS list, and the ad account and pixel data.
- ✓Contract length and exit terms. The minimum term, and what happens to patients and subscriptions if you leave.
- ✓Patient support. Who answers patient messages, refunds and shipping questions, and who handles clinical questions.
12 questions to ask any white label telehealth vendor
- In which states are your providers licensed, for each treatment I plan to offer?
- Who is the medical group, and who is the medical director?
- Which pharmacies will fill my orders, and what happens when one is backed up?
- How will my marketing name the compounding pharmacy where required?
- Whose merchant account processes my payments, and what is the plan if it is frozen?
- Do you apply for LegitScript certification for me, or do I?
- Who owns the patient records, the email and SMS list, and the ad account data?
- What is the minimum contract term, and what are the exit terms?
- If I leave, how do active patients and subscriptions move with me?
- Who answers patient messages, and how quickly?
- What reporting will I see on encounters, approvals, orders and refunds?
- Who is responsible for getting patients, and what does that plan look like in month one?
If question 12 gets a shrug, you are buying a store with no traffic. Budget for marketing before you sign.
White label peptides and GLP-1 programs: what each can legally claim
“White label peptides” and a “white label GLP-1 program” can mean two very different businesses. Know which one you are building before you write an ad.
| Prescribed, provider-led program | RUO (research use only) product line | |
|---|---|---|
| What it is | A licensed provider evaluates each patient, and a licensed pharmacy fills the prescription | Products sold for laboratory research, not for people to take |
| Needs telehealth infrastructure | Yes: providers, pharmacy, intake, payments | No medical group involved |
| What marketing can say | Describe the program, the provider review and the patient experience | Describe the product as a research material only |
| What marketing cannot say | That compounded drugs are FDA-approved, generic, or the same as Ozempic, Wegovy, Mounjaro or Zepbound. That a pharmacy is “FDA-approved” or “FDA-licensed.” Promised weight loss or other outcomes | Any health claim, any dosing, anything suggesting human use |
What the FDA has done in 2026. On 3 March 2026, the FDA sent 30 warning letters to telehealth companies. The issues included compounded products presented as effectively the same as approved drugs, and private-label branding that hid who made the drug. On 16 June 2026, 25 more letters followed. Those cited labels implying the seller was the compounder, claims that compounded drugs were FDA-approved, and pharmacies called “FDA-approved” or “FDA-licensed.”
Where peptides stand. In April 2026, the FDA removed 12 peptides, including BPC-157 and TB-500, from its Category 2 list (substances raising significant safety concerns for compounding). Removal is not approval. In July 2026, an FDA advisory committee voted to recommend BPC-157 (8 to 6) and KPV for the 503A bulks list, the list of substances a 503A compounding pharmacy (a state-licensed pharmacy that prepares medications for individual patient prescriptions) may use. That is advice, not a final rule. Formal rulemaking must follow.
This is educational, not legal advice. Rules vary by state, and we are not lawyers. Work with healthcare counsel before you launch either model. For the marketing side, see GLP-1 marketing and peptide marketing.
What a done-for-you launch adds that a platform does not
A done-for-you launch puts infrastructure and growth under one roof. ModFX builds your brand on Heroship or Wizlo, then runs the ads, provider pages, AI-assisted creative and follow-up that bring patients in. See the full stack in telehealth infrastructure, explained.
From the field
Founders often tell me the platform is the big decision. In my experience it is the smaller one. I built and ran seven clinics, and the hard part was never the building. It was getting the right patients through the door at a cost that left a margin. White label platforms solve the building. So ask every vendor who solves the patients. If the answer is “you do,” that can be fine. Just have a real plan and a real budget for it before you sign.
Justin Ingram
ThriveLab
an eight-figure telehealth brand: ModFX runs all of its marketing.
Game Day Men’s Health
our team scaled it from a single founder-run location into a national brand on paid direct response.
Who should not choose a done-for-you launch
We will tell you where we are not the fit. Here is where a done-for-you launch is usually the wrong call.
- You already have an audience and a marketing team. A self-serve white label platform may be all you need, at least to start.
- You have engineers, a medical group and compliance staff. A custom build or your own stack may fit better. If you want marketing on top, we do that too. ThriveLab owns its own professional corporation, and we run its marketing.
- You only want an RUO product line. That is not telehealth. You do not need a medical group or a telehealth platform.
- You want a guaranteed result or a fixed launch date. Nobody honest can promise either, and we will not.
- You are not ready to invest in getting patients. Infrastructure alone will sit empty.
See real launches in our telehealth marketing case studies, or start with how to start a telehealth business and our telehealth launch and marketing agency hub.
What happens on the strategy call
What we cover
Where you are today and where you want to be in 12 months. Your treatments, states and timeline. What is already working and what is leaking. The path we would take, in order, and whether we are the right team for it. If we are not, we will tell you who is.
What to bring
Your treatment list and target states. Current numbers if you are live (ad spend, new patients, refill rate). The platforms or vendors you are considering. Rough is fine.
About cost: Every launch is scoped to your states, product mix and goals, so we put real numbers in front of you on the call.
Book a strategy callYou will leave knowing which of the three launch paths fits your audience, budget and timeline, even if the answer is a self-serve platform instead of us.
FAQ
+What is the difference between a white label telehealth platform and a turnkey telehealth platform?
The terms overlap. A white label telehealth platform lets you sell under your own brand on a vendor’s medical group, pharmacies and software. “Turnkey” usually means it is preconfigured so you can launch with little setup. Neither term tells you who brings in patients. Ask every vendor that directly, along with who owns the data and what the exit terms are.
+Do I own my patients on a white label telehealth platform?
It depends on the contract. On many platforms the vendor’s medical group holds the patient charts and the vendor’s processor holds the subscriptions, even though patients see your brand. Ask who owns the records, the email and SMS list and the ad data, and how patients move if you leave. Get the answers in writing before you sign.
+Can I sell white label peptides through telehealth?
It depends on the model. A prescribed peptide program runs through licensed providers and a licensed pharmacy, and its marketing must avoid unapproved claims. An RUO (research use only) product line is not telehealth and cannot make health claims or give dosing. As of October 2026, rules are shifting and vary by state, so work with healthcare counsel. We update this page quarterly.
+Can I start on a self-serve platform and move to ModFX later?
Yes, and some founders do. You can keep your current platform and have ModFX market on top of it, or move to Heroship or Wizlo when you outgrow it. If you might move later, ask your vendor now how patients, subscriptions and data transfer out. That one answer decides how painful a move will be.
+How should I compare white label telehealth pricing?
Compare the total cost to get one paying patient, not just the platform fee. Ask each vendor for every fee: setup, monthly, per encounter, pharmacy and processing. Then add what you will spend on marketing. Every ModFX launch is scoped to your states, product mix and goals, so we put real numbers in front of you on the call.
Pick your launch path with the facts in front of you
Bring the vendors you are considering, and we will walk through the trade-offs with you, including when one of them fits better than we do.
Help me choose a launch pathSources
- FDA’s Latest GLP-1 Crackdown: What Compounders and Telehealth Platforms Need to Know (Venable LLP)
- FDA takes aim at misleading online claims for compounded GLP-1 drugs (McDermott)
- FDA Peptide Update: What the Recent BPC-157, KPV, and TB-500 News Means (Yoo Direct Health)
- Recent Regulatory Updates on Compounded Peptide Injections (New Drug Loft and VLS Pharmacy)
ModFX Media is a marketing agency, not a medical provider, pharmacy or law firm. This page is educational and is not medical or legal advice. Whether a treatment is right for a patient is decided by a licensed provider, and availability depends on the medication and state rules.